Aims. The aim of this study was to report the mid-term clinical outcome
of cemented unlinked J-alumina ceramic elbow (JACE) arthroplasties
when used in patients with rheumatoid arthritis (RA). Patients and Methods. We retrospectively reviewed 87 elbows, in 75 patients with RA,
which was replaced using a cemented JACE total elbow arthroplasty
(TEA) between August 2003 and December 2012, with a follow-up of
96%. There were 72 women and three men, with a mean age of 62 years
(35 to 79). The mean follow-up was nine years (2 to 14). The clinical condition
of each elbow before and after surgery was assessed using the Mayo
Elbow Performance Index (MEPI, 0 to 100 points). Radiographic loosening
was defined as a progressive radiolucent line of >1 mm that was
completely circumferential around the prosthesis. Results. The mean MEPI scores significantly improved from 40 (10 to 75)
points preoperatively to 95 (30 to 100) points at final follow-up
(p < 0.0001). Complications were noted in ten elbows (ten patients;
11%). Two had an intraoperative humeral fracture which was treated
by fixation and united. One had a postoperative fracture of the
olecranon which united with conservative treatment and one had a
radial neuropathy which resolved. Further surgery was required for
one with a dislocation, three with an ulnar neuropathy and one with
a postoperative humeral fracture. Revision with removal of the components
was performed in one elbow due to